carbamates has been researched along with istradefylline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gal, S; Geldenhuys, WJ; Van der Schyf, CJ; Youdim, MB | 1 |
| Hussar, DA | 1 |
1 review(s) available for carbamates and istradefylline
| Article | Year |
|---|---|
Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases.
Topics: Acetylcholine; Adenosine A2 Receptor Antagonists; Animals; Apoptosis; Calcium; Calcium Channel Blockers; Carbamates; Cholinesterase Inhibitors; Drug Design; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Humans; Hydroxyquinolines; Iron Chelating Agents; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Neuroprotective Agents; Piperazines; Purines; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2006 |
1 other study(ies) available for carbamates and istradefylline
| Article | Year |
|---|---|
New Drugs 2020, part 1.
Topics: Antibodies, Monoclonal; Benzofurans; Carbamates; Drug Approval; Humans; Phenylalanine; Piperidines; Purines; Tetracyclines; United States; United States Food and Drug Administration | 2020 |